These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation. Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608 [TBL] [Abstract][Full Text] [Related]
12. Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation. Kappert K; Paulsson J; Sparwel J; Leppänen O; Hellberg C; Ostman A; Micke P FASEB J; 2007 Feb; 21(2):523-34. PubMed ID: 17158785 [TBL] [Abstract][Full Text] [Related]
13. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Uzui H; Lee JD; Shimizu H; Tsutani H; Ueda T Atherosclerosis; 2000 Mar; 149(1):51-9. PubMed ID: 10704614 [TBL] [Abstract][Full Text] [Related]
14. Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. Hayashi K; Shibata K; Morita T; Iwasaki K; Watanabe M; Sobue K J Biol Chem; 2004 Sep; 279(39):40807-18. PubMed ID: 15272025 [TBL] [Abstract][Full Text] [Related]